Slideshow
Author(s):
CMEs offered by the American Academy of Neurology, Cleveland Clinic, Mayo Clinic, and the American Medical Association.
Insights From the TRAILBLAZER-ALZ Program: Elevated ARIA Risk with Donanemab Highlights the Need for Vigilant Monitoring
Special Episode: FDA Approves Tenecteplase for Acute Ischemic Stroke
Misdiagnosed Migraine Leads to Significant Burden on Healthcare Resource Utilization
Episode 136: Raising Epilepsy Awareness for Purple Day
Blueprints for Better Care: 2024 Neurology Guideline Highlights
NeuroVoices: Tanya Simuni, MD, FAAN, on Using the Neuronal α-Synuclein Disease Integrated Staging System Framework to Advance Parkinson Disease Staging